Medline Inc (MDLN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Medline Inc (MDLN) is down 16.0% since the beginning of the year. At $35 per share, MDLN is trading 30.6% below its 52-week high of $51.

Based on dividend-adjusted daily data since Dec 17, 2025, MDLN's average daily return is +0.05%, while the average monthly return is +0.73%. At this rate, an investment would double in approximately 7.9 years.

Historically, 43% of months were positive and 57% were negative. The best month was Dec 2025 with a return of +20.0%, while the worst month was May 2026 at -17.8%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 4 months.

On a daily basis, MDLN closed higher 48% of trading days. The best single day was Dec 17, 2025 with a return of +17.1%, while the worst single day was May 6, 2026 at -7.3%.

Medline Inc has an annualized alpha of 9.32%, beta of 0.25, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since December 17, 2025.

• This stock participated in 35.51% of S&P 500 Index downside but only 17.63% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.25 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Medline Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Medline Inc was 33.61%, occurring on Jun 2, 2026. The portfolio has not yet recovered.

The current Medline Inc drawdown is 29.39%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Medline Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Medline Inc is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.